Cohesin RAD21 Gene Promoter Methylation in Patients with Chronic Lymphocytic Leukemia
Overview
Authors
Affiliations
Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in adults and is characterized by the presence of specific cytogenetic abnormalities. CLL research has been focused on epigenetic processes like gene promoter methylation of CpG islands. In the present study, the methylation status of the RAD21 gene is studied and associated with cytogenetic findings in CLL patients in order to investigate its possible implication in CLL pathogenesis and the formation of CLL chromosomal abnormalities.
Cohesin Gene Promoter Methylation in Patients with Acute Myeloid Leukemia.
Manola K, Zachaki S, Kakosaiou K, Ioannidou A, Kalomoiraki M, Rampias T Life (Basel). 2024; 14(10).
PMID: 39459611 PMC: 11509327. DOI: 10.3390/life14101311.
Chatzidavid S, Kontandreopoulou C, Giannakopoulou N, Diamantopoulos P, Stafylidis C, Kyrtsonis M Adv Hematol. 2024; 2024:1370364.
PMID: 38435839 PMC: 10907108. DOI: 10.1155/2024/1370364.
Cohesin subunit RAD21: From biology to disease.
Cheng H, Zhang N, Pati D Gene. 2020; 758:144966.
PMID: 32687945 PMC: 7949736. DOI: 10.1016/j.gene.2020.144966.